Surgical embolectomy versus thrombolytic therapy in the management of acute massive pulmonary embolism: Short and long-term prognosis

Heart Lung. 2015 Jul-Aug;44(4):335-9. doi: 10.1016/j.hrtlng.2015.04.008.

Abstract

Objective: Comparison between surgical embolectomy and thrombolytic therapy in patients suffering from acute massive pulmonary embolism (AMPE).

Background: Prompt treatment of AMPE is necessary, although optimal management is a matter of debate.

Methods: Patients with AMPE were assigned to either thrombolytic therapy or pulmonary surgical embolectomy. Early and late mortality, systolic pulmonary artery pressure (SPAP), right ventricular diameter (RVD) and bleeding complications were evaluated.

Results: Seventy eight patients were treated with thrombolytic therapy and 30 patients underwent surgery. The difference between pre-intervention and third-day post-intervention in terms of RVD and SPAP was significantly greater in patients under surgical embolectomy (P < 0.001). There was a significant decline in RVD and SPAP in both groups during follow-up (P < 0.001). Mortality rate in the surgical embolectomy group was lower than the thrombolytic group although not significantly.

Conclusion: Early surgical treatment was associated with fewer complications in comparison to thrombolytic therapy.

Keywords: Echocardiography; Embolectomy; Pulmonary embolism; Thrombolytic therapy.

Publication types

  • Clinical Study
  • Comparative Study

MeSH terms

  • Acute Disease
  • Analysis of Variance
  • Embolectomy / methods*
  • Embolectomy / mortality
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Pulmonary Embolism / therapy*
  • Thrombolytic Therapy / methods*
  • Thrombolytic Therapy / mortality

Substances

  • Fibrinolytic Agents